Patents by Inventor Saran Narang

Saran Narang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8715659
    Abstract: A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags (His5 is SEQ ID NO:101). Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: May 6, 2014
    Assignee: National Research Council of Canada
    Inventors: Arumugam Muruganandam, Jamshid Tanha, Saran Narang, Danica Stanimirovic
  • Patent number: 8383107
    Abstract: A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags (His5 is SEQ ID NO:101). Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: February 26, 2013
    Assignee: National Research Council of Canada
    Inventors: Arumugam Muruganandam, Jamshid Tanha, Saran Narang, Danica Stanimirovic
  • Patent number: 8372954
    Abstract: Phage display libraries are taught in which the recombinant phage population displays a plurality of potential binding fragments having preferred characteristics of solubility and/or intermolecular interaction. Also taught are methods of biasing display libraries to produce variants which more closely approximate the preferred characteristics of the parental binding fragment.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: February 12, 2013
    Assignee: National Research Council of Canada
    Inventors: Jamshid Tanha, Joycelyn Entwistle, Saran Narang, Michael Dan, Colin R. Mackenzie, Carole Grad
  • Patent number: 8257705
    Abstract: A phage display library of variable heavy domain (VHH or VH) fragments (sdAb fragments) derived from the antibody repertoire of a non-immunized llama is disclosed. The sdAb fragments of the library are characterized by the absence of cysteine residues in complementarity determining regions (CDRs) and a very low presence of residues of glutamic acid, arginine and glycine at positions 44, 45 and 47, respectively, of the VL interface of the variable heavy domain VHH. The large size of the library (in the order of 109) makes it a source of antigen-binding fragments having high affinity to almost any antigen of interest. The library is preferably generated using a modified fd-tet phage growing in plaques in the absence of a tetracycline.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: September 4, 2012
    Assignee: National Research Council of Canada
    Inventors: Jamshid Tanha, Ginette Dubuc, Saran Narang
  • Publication number: 20110171720
    Abstract: A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags. Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Application
    Filed: March 21, 2011
    Publication date: July 14, 2011
    Applicant: National Research Council of Canada NRC Communications & Corporate Relations
    Inventors: Arumugam Muruganandam, Jasmid Tanha, Saran Narang, Danica Stanimirovic
  • Patent number: 7943129
    Abstract: A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags. Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: May 17, 2011
    Assignee: National Research Council of Canada
    Inventors: Arumugam Muruganandam, Jasmid Tanha, Saran Narang, Danica Stanimirovic
  • Publication number: 20090162422
    Abstract: A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags. Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Application
    Filed: July 23, 2007
    Publication date: June 25, 2009
    Applicants: the National Research Council Act by the Parliament of Canada
    Inventors: Arumugam Muruganandam, Jamshid Tanha, Saran Narang, Danica Stanimirovic
  • Publication number: 20080124324
    Abstract: A phage display library of variable heavy domain (VHH or VH) fragments (sdAb fragments) derived from the antibody repertoire of a non-immunized llama is disclosed. The sdAb fragments of the library are characterized by the absence of cysteine residues in complementarity determining regions (CDRs) and a very low presence of residues of glutamic acid, arginine and glycine at positions 44, 45 and 47, respectively, of the VL interface of the variable heavy domain VHH. The large size of the library (in the order of 109) makes it a source of antigen-binding fragments having high affinity to almost any antigen of interest. The library is preferably generated using a modified fd-tet phage growing in plaques in the absence of a tetracycline.
    Type: Application
    Filed: June 29, 2006
    Publication date: May 29, 2008
    Applicant: National Research Council of Canada
    Inventors: Jasmid Tanha, Ginette Dubuc, Saran Narang
  • Publication number: 20060246058
    Abstract: A phage display library of variable heavy domain (VHH or VH) fragments (sdAb fragments) derived from the antibody repertoire of a non-immunized llama is disclosed. The sdAb fragments of the library are characterized by the absence of cysteine residues in complementarity determining regions (CDRs) and a very low presence of residues of glutamic acid, arginine and glycine at positions 44, 45 and 47, respectively, of the VL interface of the variable heavy domain VHH. The large size of the library (in the order of 109) makes it a source of antigen-binding fragments having high affinity to almost any antigen of interest. The library is preferably generated using a modified fd-tet phage growing in plaques in the absence of a tetracycline.
    Type: Application
    Filed: June 29, 2006
    Publication date: November 2, 2006
    Applicant: National Research Council of Canada
    Inventors: Jasmid Tanha, Ginette Dubuc, Saran Narang
  • Publication number: 20050164180
    Abstract: Phage display libraries are taught in which the recombinant phage population displays a plurality of potential binding fragments having preferred characteristics of solubility and/or intermolecular interaction. Also taught are methods of biasing display libraries to produce variants which more closely approximate the preferred characteristics of the parental binding fragment.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 28, 2005
    Inventors: Jamshid Tanha, Joycelyn Entwistle, Saran Narang, Michael Dan, Colin Mackenzie, Howard Kaplan, Carole Grad
  • Publication number: 20040161738
    Abstract: A phase-displayed library if llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags. Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
    Type: Application
    Filed: October 24, 2003
    Publication date: August 19, 2004
    Inventors: Arumugam Muruganandam, Jasmid Tanha, Saran Narang, Danica Stanimirovic
  • Publication number: 20030190598
    Abstract: A phage display library of variable heavy domain (VHH or VH) fragments (sdAb fragments) derived from the antibody repertoire of a non-immunized llama is disclosed. The sdAb fragments of the library are characterized by the absence of cysteine residues in complementarity determining regions (CDRs) and a very low presence of residues of glutamic acid, arginine and glycine at positions 44, 45 and 47 respectively, of the VL interface of the variable heavy domain VHH. The large size of the library (in the order of 109) makes it a source of antigen-binding fragments having high affinity to almost any antigen of interest. The library is preferably generated using a modified fd-tet phage growing in plaques in the absence of a tetracycline.
    Type: Application
    Filed: November 14, 2002
    Publication date: October 9, 2003
    Inventors: Jasmid Tanha, Ginette Dubuc, Saran Narang
  • Patent number: 5021337
    Abstract: A process is described for monitoring the production of recombinant proteins. It is based on the discovery that infrared spectra of E. coli strains and transformants which overproduce recombinant proteins can be measured as a function of pressure, and a pressure-induced distinct shifting pattern can be observed in specific spectral parameters of transformants. In particular, the difference in the pressure-induced shift of the amide III band, between the E. coli cells and the transformants over-producing the recombinant proteins provides an efficient and non-intrusive technique for on-line monitoring of the production of recombinant proteins in E. coli.
    Type: Grant
    Filed: July 15, 1988
    Date of Patent: June 4, 1991
    Assignee: National Research Council of Canada
    Inventors: Patrick T. T. Wong, Saran A. Narang, Wing L. Sung
  • Patent number: 4830965
    Abstract: Transposable linkers are DNA sequences recognized and employed by transposition proteins, including transposases, in the insertion of genetic information into the genetic architecture of an organism and in the movement of genetic information from one location to another in the genetic architecture of an organism. Such linkers, comprising the extreme ends of transposons, often referred to as left and right attachment sites, have been isolated from the intervening material in transposons to produce a basic building block comprising simply the extreme ends of the transposons fused together. Using restriction endonuclease recognition sites outside and between the left and right attachment sites it is possible to introduce desired genes directly or via cloning vehicles, into the genetic material of an organism.
    Type: Grant
    Filed: June 10, 1987
    Date of Patent: May 16, 1989
    Assignees: Canadian Patents and Development Ltd., Cold Spring Harbor Laboratory
    Inventors: Saran A. Narang, John Goodchild, Ahmad I. Bukhari, deceased
  • Patent number: 4792602
    Abstract: A human-like proinsulin gene and its analogs, have been synthesized by a combination of chemical and enzymatic methods. A number of different human-like proinsulin gene analogs with altered C-chains have also been designed and can be readily constructed as described. As a part of the strategy, an adaptor for trimming DNA has been designed, synthesized and used to recover the A-chain insulin gene with the desired sequence from a hybrid plasmid; a related adaptor for trimming DNA has been designed to shorten the C-chain gene or any gene. The synthetic proinsulin gene has been joined to a replicable cloning vehicle and the hybrid DNA transferred to a host cell. The transformed host cell has been shown to contain the desired human-like proinsulin gene.
    Type: Grant
    Filed: December 16, 1983
    Date of Patent: December 20, 1988
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Saran A. Narang, Ray J. Wu
  • Patent number: 4617384
    Abstract: Adaptor molecules have been prepared to comprise either start or stop signals for protein synthesis, in addition to recognition sites for restriction endonucleases. Separate adaptors may be used in a symmetrical duplex form. The start adaptor may include nucleotide base inserts to provide the correct reading frame of the triplet code in a DNA sequence with inappropriate reading frame. Insulin A-chain and B-chain genes of the human type, have been synthesized with the appropriate adaptor molecules provided on each end. The adapted DNA genes have been joined to replicable cloning vehicles and the hybrid DNA transferred to a host cell. The transformed host cell has been shown to contain the desired insulin gene.
    Type: Grant
    Filed: September 29, 1982
    Date of Patent: October 14, 1986
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Saran A. Narang, Ray J. Wu
  • Patent number: 4321365
    Abstract: Synthetic oligonucleotides have been designed and prepared which are useful in the molecular cloning of a variety of DNA molecules. By means of such oligonucleotides, genetic informational material, e.g., DNA, can be joined to a cloning vehicle and transferred into host cells by transformation. Additionally, a method for determining whether genetic informational material has been transferred into transformed host cells has been developed.
    Type: Grant
    Filed: October 19, 1977
    Date of Patent: March 23, 1982
    Assignee: Research Corporation
    Inventors: Ray J. Wu, Chander P. Bahl, Saran A. Narang
  • Patent number: 4059592
    Abstract: Arylsulfonyl tetrazoles of the formula ##STR1## where R.sub.1, R.sub.2 and R.sub.3 are selected from hydrogen, lower alkyl and lower alkoxy groups, and their preparation are described.These compounds have been found to be advantageous condensing or coupling agents via phosphoester formation in polynucleotide synthesis.
    Type: Grant
    Filed: February 10, 1976
    Date of Patent: November 22, 1977
    Assignee: Canadian Patents and Development Limited
    Inventors: Saran A. Narang, Jacek Stawinski